Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients: A Randomized Controlled Trial.

NCT04497649 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT04497649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04497649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients: A Randomized Controlled Trial.
Lead sponsor
Tanta University
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 1, 2020
Completion date
April 10, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19